Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merrion Announces License Agreement with Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonist(s)
Merrion Announces License Agreement with Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonist(s)
Merrion Announces License Agreement with Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonist(s)
Submitted by
admin
on January 16, 2009 - 11:08am
Source:
Pharma Live
News Tags:
Merrion
Novo Nordisk
Headline:
Merrion Announces License Agreement with Novo Nordisk to Develop Oral Formulation of GLP-1 Receptor Agonist(s)
Do Not Allow Advertisers to Use My Personal information
